- Home
- CVLT vs ADMA Comparison
CVLT vs ADMA Comparison
Compare CVLT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVLT
- ADMA
- Stock Information
- Founded
- CVLT 1996
- ADMA 2004
- Country
- CVLT United States
- ADMA United States
- Employees
- CVLT N/A
- ADMA N/A
- Industry
- CVLT Computer Software: Prepackaged Software
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVLT Technology
- ADMA Health Care
- Exchange
- CVLT Nasdaq
- ADMA Nasdaq
- Market Cap
- CVLT 6.8B
- ADMA 5.8B
- IPO Year
- CVLT 2006
- ADMA N/A
- Fundamental
- Price
- CVLT $170.60
- ADMA $19.98
- Analyst Decision
- CVLT Buy
- ADMA Strong Buy
- Analyst Count
- CVLT 11
- ADMA 4
- Target Price
- CVLT $173.33
- ADMA $24.25
- AVG Volume (30 Days)
- CVLT 473.7K
- ADMA 4.6M
- Earning Date
- CVLT 04-29-2025
- ADMA 05-07-2025
- Dividend Yield
- CVLT N/A
- ADMA N/A
- EPS Growth
- CVLT N/A
- ADMA N/A
- EPS
- CVLT 1.68
- ADMA 0.84
- Revenue
- CVLT $995,619,000.00
- ADMA $459,381,000.00
- Revenue This Year
- CVLT $13.00
- ADMA $18.45
- Revenue Next Year
- CVLT $11.11
- ADMA $26.96
- P/E Ratio
- CVLT $101.55
- ADMA $23.91
- Revenue Growth
- CVLT 18.63
- ADMA 62.23
- 52 Week Low
- CVLT $105.76
- ADMA $6.84
- 52 Week High
- CVLT $190.11
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- CVLT 57.21
- ADMA 43.06
- Support Level
- CVLT $167.99
- ADMA $18.75
- Resistance Level
- CVLT $178.53
- ADMA $23.98
- Average True Range (ATR)
- CVLT 6.75
- ADMA 1.38
- MACD
- CVLT 1.48
- ADMA -0.34
- Stochastic Oscillator
- CVLT 76.91
- ADMA 17.77
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.